Vaccinating transplant recipients

Article metrics

Immunity is partly destroyed by the effects of high-dose chemotherapy associated with hematopoietic stem cell transplantation. A new strategy restores impaired immunity in people and offers clues to improving vaccination against pathogens and tumors (pages 1230–1237).

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Immune reconstitution after hematopoietic stem cell transplantation (HSCT).

References

  1. 1

    Rapoport, A.P. et al. Nat. Med. 11, 1230–1237 (2005)

  2. 2

    Storek, J. et al. Blood 101, 3319–3324 (2003).

  3. 3

    Fry, T.J. & Mackall, C.L. Bone Marrow Transplant. 35 Suppl 1, S53–S57 (2005).

  4. 4

    Goldrath, A.W. & Bevan, M.J. Immunity 11, 183–190 (1999).

  5. 5

    Liebowitz, D.N., Lee, K.P. & June, C.H. Curr. Opin. Oncol. 10, 533–541 (1998).

  6. 6

    Molldrem, J.J. et al. J. Clin. Invest. 111, 639–647 (2003).

  7. 7

    Fry, T.J. et al. Blood 97, 1525–1533 (2001).

  8. 8

    Mackall, C.L., Hakim, F.T. & Gress, R.E. Immunol. Today 18, 245–251 (1997).

  9. 9

    Watanabe, N. et al. Nat. Immunol. 5, 426–434 (2004).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Molldrem, J. Vaccinating transplant recipients. Nat Med 11, 1162–1163 (2005) doi:10.1038/nm1105-1162

Download citation

Further reading